SCHEMBL25894

SCHEMBL25894

C1=Cc2ccccc2[N]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL211354 0.82 TRPA1 (0.30) —
SCHEMBL1245585 0.80 KDM4E (0.35) —
Quinoline SCHEMBL1162952 0.74 TRPA1 (0.31) —
Cinnoline SCHEMBL450150 0.74 TRPA1 (0.31) —
SCHEMBL1395835 0.74 ALDH1A1 (0.36) —
SCHEMBL206344 0.72 TRPA1 (0.34) —
Quinoxaline SCHEMBL451431 0.72 ALDH1A1 (0.33) —
SCHEMBL6843536 0.71 MAPT (0.39) —
SCHEMBL9432585 0.71 ALDH1A1 (0.38) —
SCHEMBL10434951 0.71 MAPT (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 9433 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024145659-A1 HETEROCYCLE FUSED GAMMA-CARBOLINES ACTING ON THE SEROTONINE 5-HT2A RECEPTOR INTRA-CELLULAR THERAPIES, INC. (US) 2024-07-04 — — WO claimed
CN-118253348-A Carbonylation catalyst, preparation method and application thereof 万华化学集团股份有限公司 2024-06-28 — — CN claimed
WO-2024112258-A1 SEROTONIN RECEPTOR AS A TARGET FOR THERAPY AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2024-05-30 — — WO claimed
EP-4361141-A1 PROTEIN DEGRADATION AGENT Suzhou Kintor Pharmaceuticals, Inc. (CN) 2024-05-01 — — EP claimed
CN-117940431-A Compound, light-emitting material, and light-emitting element 九州有机光材股份有限公司 2024-04-26 — — CN claimed
WO-2024074641-A1 METHOD FOR PREPARING AMIDES FROM ESTERS BASF SE (DE) 2024-04-11 — — WO claimed
US-20240059726-A1 GLYCOSYLATED HISTONE DEACETYLASE INHIBITORS AND METHODS OF MAKING AND USING THE SAME GEORGIA TECH RESEARCH CORPORATION 2024-02-22 — — US claimed
CN-117545749-A Protein degradation agent 苏州开拓药业股份有限公司 2024-02-09 — — CN claimed
WO-2024027694-A1 PROTEIN DEGRADATION AGENT 苏州开拓药业股份有限公司 2024-02-08 — — WO claimed
CN-117466884-A Heterocyclic compounds or salts thereof as ATR kinase inhibitors, pharmaceutical compositions containing same and uses thereof 德州大学系统董事会 2024-01-30 — — CN claimed
EP-0039051-B1 MANNICH-BASE HYDROXAMIC ACID PRODRUGS FOR THE IMPROVED BIOAVAILABILITY OF NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, A PROCESS FOR PREPARING AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM MERCK & CO. INC. (US) 1985-07-24 — — EP claimed
EP-0148128-A2 Optically active penem compounds CIBA-GEIGY AG (CH) 1985-07-10 — — EP claimed
US-4451462-A Method of treating inflammation and pain using heteramino benzofurans CIBA-GEIGY CORPORATION (US) 1984-05-29 — — US claimed
EP-0106800-A1 Furans CIBA-GEIGY AG (CH) 1984-04-25 — — EP claimed
US-4426380-A ANTIINFLAMMATORY, ANALGESIC, SUNSCREEN CIBA-GEIGY CORPORATION (US) 1984-01-17 — — US claimed
EP-0078241-A2 Furanes CIBA-GEIGY AG (CH) 1983-05-04 — — EP claimed
EP-0051278-A1 Soft tertiary amine esters of bio-affecting carboxylic acids, processes for preparing and a pharmaceutical composition containing the same MERCK & CO. INC. (US) 1982-05-12 — — EP claimed
EP-0039051-A2 Mannich-base hydroxamic acid prodrugs for the improved bioavailability of non-steroidal anti-inflammatory agents, a process for preparing and a pharmaceutical composition containing them MERCK & CO. INC. (US) 1981-11-04 — — EP claimed
US-3957726-A S-TRIAZINE-IMIDE COPOLYMERS CIBA-GEIGY CORPORATION (US) 1976-05-18 — — US claimed
US-3946011-A S-Triazine tetracarboxylic acids and dianhydrides CIBA-GEIGY CORPORATION (US) 1976-03-23 — — US claimed
Send feedback